MetaCap

BrainsWay Ltd. ADR (BWAY)

NASDAQ: BWAYHealth CareMedical/Dental InstrumentsUSD

8.48-0.25 (-2.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BWAY stock chart

Technical analysis

Key statistics

All statistics
Market cap
$341.35M
52-week range
7.30 – 17.40
Day range
8.45 – 8.96
Volume / Avg
109.52K / 110.35K
Beta
—

52-week range

$7.30$17.40

BWAY stock today

Shares of BrainsWay (BWAY) finished lower on Nov 20 at $8.48, a drop of 2.86% or $0.25 per share, versus the S&P 500's 3.70% decline. Shares are 51.3% below their 52-week high of $17.40, set on Aug 12, 2026 and 16.2% above the 52-week low of $7.30, near the bottom of the past year's range. BWAY is down 10.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 13.9%.

At 35.3x trailing earnings, BrainsWay trades above the peer-group median of 18.0x. Its forward P/E of 17.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About BrainsWay

Company profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.

Industry
Medical/Dental Instruments
CEO
Mr. Hadar Levy
Headquarters
Jerusalem
Employees
129
IPO year
2019

Financial highlights

Full financials

In fiscal 2024, BrainsWay generated $41.0 million in revenue, up 29.0% from fiscal 2023, its 2nd consecutive year of revenue growth. Net income was $2.9 million, for a net margin of 7.1% versus a median of -24.4% in the prior 5 years. Gross margin was 74.6% (up from 73.9%) and operating margin 3.4%.

BrainsWay annual revenue, net income and EPS
Fiscal yearFY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$41.02M$31.79M$27.18M$29.66M$22.06M
Growth+29.04%+16.96%-8.36%+34.46%-4.52%
Net income$2.92M$-4.20M$-13.35M$-6.46M$-5.38M
EPS (diluted)$0.05$-0.13$-0.40$-0.21—

Analyst forecast

Forecast

Consensus (3 analysts)

strong_buy

Avg. price target

$19.27+127.24%

  • Strong buy 0
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $18.80High $20.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 10, 2026
EPS actual vs est.
$0.04 vs $0.12
Surprise
-66.67%

BWAY news

All BWAY news

BrainsWay peers

Health Care sector
BWAY peer companies
CompanyPrice% ChgMarket capCompare
EMBCEmbecta Corp.6.02-2.75%$341.09Mvs BWAY
CERSCerus Corporation1.85-2.63%$373.62Mvs BWAY
MOBIMobia Medical Inc.11.85-0.08%$394.50Mvs BWAY
INFUInfuSystems Holdings Inc.14.35+2.06%$287.48Mvs BWAY
TMCITreace Medical Concepts Inc.4.31-0.92%$282.56Mvs BWAY
NPCENeuropace Inc.7.95-2.33%$273.89Mvs BWAY
SIShoulder Innovations Inc.20.15-0.79%$421.58Mvs BWAY
SSIISS Innovations International Inc.1.27-0.78%$254.86Mvs BWAY

Indexes, lists and sector

BrainsWay stock FAQ

What is BrainsWay's stock price today?

BWAY last traded at $8.48 as of Nov 20, 4:00 PM EST, down 2.86% on the day. Prices are delayed at least 15 minutes.

Does BrainsWay pay a dividend?

No. BrainsWay does not currently pay a regular cash dividend.

What is BWAY's P/E ratio?

BWAY trades at a trailing P/E ratio of 35.33 and a forward P/E of 16.96, compared with a median of 18.0 for its closest peers.

Who is BrainsWay's CEO?

Mr. Hadar Levy is the chief executive officer of BrainsWay Ltd. ADR, which has about 129 employees.

Has BWAY ever split its stock?

Yes. The most recent BWAY stock split was a 2-for-1 split on Mar 4, 2026.

What is the BWAY 52-week high?

The 52-week high for BWAY is $17.40 and the 52-week low is $7.30. The stock is currently 51.3% below its high.

Compare BWAY